This section considers studies regarding all aspects of endocrinology and diabetology in children and adolescents.
Prevalence of children born small for gestational age with short stature who qualify for growth hormone treatment
Recombinant human growth hormone (rhGH) is approved in Europe as a treatment for short children born small for gestational age (SGA) since 2003. However, no study evaluated the prevalence of SGA children with ...
Citation: Italian Journal of Pediatrics 2021 47:82